Cetacaine Anesthetic Aerosol, Spray
Product Images NDC 10223-0201

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Cetacaine Anesthetic (NDC 10223-0201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cetylite Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cetacaine 01

Packaging label for Cetacaine Anesthetic topical spray, containing benzocaine 14.0%, butamben 2.0%, and tetracaine hydrochloride 2.0%. The label highlights use on mucous membranes with indications for controlling pain and gagging. It includes directions for use, active ingredient concentrations, and manufacturer information for Cetylite Industries, Inc. The net contents are 20 g with proprietary propellant.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.